GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (WBO:LLYC) » Definitions » Float Percentage Of Total Shares Outstanding

Eli Lilly and Co (WBO:LLYC) Float Percentage Of Total Shares Outstanding : 88.77% (As of Dec. 15, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Eli Lilly and Co Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Eli Lilly and Co's float shares is 798.35 Mil. Eli Lilly and Co's total shares outstanding is 899.32 Mil. Eli Lilly and Co's float percentage of total shares outstanding is 88.77%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Eli Lilly and Co's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Eli Lilly and Co's Institutional Ownership is 51.97%.

Eli Lilly and Co Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Eli Lilly and Co's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=798.35/899.32
=88.77%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eli Lilly and Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (WBO:LLYC) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
JNJ ABBV MRK AMGN PFE BMY GILD BIIB OGN AMRN OCSE:NOVO B XSWX:ROG XSWX:NOVN LSE:AZN XPAR:SAN LSE:GSK TSE:4519 TSE:4568 SHSE:600276 TSE:4578
Traded in Other Exchanges
LLY:USA LLY:Mexico 1LLY:Italy LLY0:Germany LLY:Germany LLY:Germany LLY:Germany LLY:Germany LLYCL:Chile LLY:Switzerland LLY:Canada LILY34:Brazil LLY:Bulgaria LLY:Argentina
Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Website
https://www.lilly.com
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Eli Lilly and Co Headlines

No Headlines